"Although the British and U.S. health care systems differ markedly, some policy experts in both countries see improving health care value propositions as one solution to the conundrum of sky-rocketing costs and limited resources."
Determining the value of drugs — the evolving British experience
RR Faden, K Chalkidou
New England Journal of Medicine, 2011, 6th April
Read more here.
No comments:
Post a Comment